There are several potential challengers to Novo Nordisk and Eli Lilly’s obesity drugs, and Jefferies analysts see one as ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

The city of Greensboro has joined a national litigation campaign suing the nation's three largest pharmacy benefit managers and three largest insulin manufacturers with the goal of lowering insulin pr ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024.

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Darzalex, which treats multiple myeloma, has become the first Johnson & Johnson drug to ever top $3 billion in quarterly ...

Seguindo com o assunto cinema, a primeira imagem de Sadie Sink em "O'Dessa", longa de Geremy Jasper que estreia no SXSW em março, foi revelada hoje (22). O filme, ambientado em um futuro ...

Lewis Hamilton demonstra grande entusiasmo com o começo na Ferrari. O piloto britânico dirigiu nesta quarta-feira o SF-23 - carro usado pela escuderia na temporada de 2023 da Fórmula 1 - em um evento ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

O resultado marcou a 19ª vitória consecutiva de Sinner no circuito. O italiano de 23 anos não perde desde o início de outubro. E vem de três títulos seguidos, um deles com a equipe do seu país na Copa ...